Chava B. Pocernich, Ph.D. - Publications

University of Kentucky, Lexington, KY 

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Pocernich C, Butterfield DA, Head E. Diet and Brain Aging: Effects on Cell and Mitochondrial Function and Structure Bioactive Food as Dietary Interventions For the Aging Population. 249-262. DOI: 10.1016/B978-0-12-397155-5.00030-1  1
2012 Pocernich CB, Butterfield DA. Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochimica Et Biophysica Acta. 1822: 625-30. PMID 22015471 DOI: 10.1016/j.bbadis.2011.10.003  1
2011 Pocernich CB, Lange ML, Sultana R, Butterfield DA. Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Current Alzheimer Research. 8: 452-69. PMID 21605052 DOI: 10.2174/156720511796391908  1
2007 Korde AS, Pettigrew LC, Craddock SD, Pocernich CB, Waldmeier PC, Maragos WF. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. Journal of Neurotrauma. 24: 895-908. PMID 17518543 DOI: 10.1089/neu.2006.0122  1
2006 Steiner J, Haughey N, Li W, Venkatesan A, Anderson C, Reid R, Malpica T, Pocernich C, Butterfield DA, Nath A. Oxidative stress and therapeutic approaches in HIV dementia. Antioxidants & Redox Signaling. 8: 2089-100. PMID 17034352 DOI: 10.1089/ars.2006.8.2089  1
2005 Pocernich CB, Sultana R, Mohmmad-Abdul H, Nath A, Butterfield DA. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Research. Brain Research Reviews. 50: 14-26. PMID 15890409 DOI: 10.1016/j.brainresrev.2005.04.002  1
2005 Pocernich CB, Boyd-Kimball D, Poon HF, Thongboonkerd V, Lynn BC, Klein JB, Calebrese V, Nath A, Butterfield DA. Proteomics analysis of human astrocytes expressing the HIV protein Tat. Brain Research. Molecular Brain Research. 133: 307-16. PMID 15710248 DOI: 10.1016/j.molbrainres.2004.10.023  1
2005 Pocernich CB, Poon HF, Boyd-Kimball D, Lynn BC, Nath A, Klein JB, Butterfield DA. Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Research. Molecular Brain Research. 133: 299-306. PMID 15710247 DOI: 10.1016/j.molbrainres.2004.10.024  1
2004 Pocernich CB, Sultana R, Hone E, Turchan J, Martins RN, Calabrese V, Nath A, Butterfield DA. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes. Journal of Neuroscience Research. 77: 532-9. PMID 15264223 DOI: 10.1002/jnr.20182  1
2004 Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC. Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochemical Research. 29: 741-6. PMID 15098936 DOI: 10.1023/B:NERE.0000018845.82808.45  1
2003 Pocernich CB, Butterfield DA. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotoxicity Research. 5: 515-20. PMID 14715435 DOI: 10.1007/BF03033161  1
2003 Butterfield DA, Pocernich CB. The glutamatergic system and Alzheimer's disease: therapeutic implications. Cns Drugs. 17: 641-52. PMID 12828500 DOI: 10.2165/00023210-200317090-00004  1
2003 Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J, Berger JR, Elford H, Nath A. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology. 60: 307-14. PMID 12552050  1
2003 Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, Butterfield DA, Major EO, Nath A. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. The Journal of Biological Chemistry. 278: 13512-9. PMID 12551932 DOI: 10.1074/jbc.M209381200  1
2002 Butterfield D, Castegna A, Pocernich C, Drake J, Scapagnini G, Calabrese V. Nutritional approaches to combat oxidative stress in Alzheimer's disease. The Journal of Nutritional Biochemistry. 13: 444. PMID 12165357 DOI: 10.1016/S0955-2863(02)00205-X  1
2002 Butterfield DA, Pocernich CB, Drake J. Elevated glutathione as a therapeutic strategy in Alzheimer's disease Drug Development Research. 56: 428-437. DOI: 10.1002/ddr.10095  1
2001 Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends in Molecular Medicine. 7: 548-54. PMID 11733217 DOI: 10.1016/S1471-4914(01)02173-6  1
2001 Pocernich CB, Cardin AL, Racine CL, Lauderback CM, Butterfield DA. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochemistry International. 39: 141-9. PMID 11408093 DOI: 10.1016/S0197-0186(01)00012-2  1
2000 Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, Cass WA. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Research. 878: 218-22. PMID 10996156 DOI: 10.1016/S0006-8993(00)02707-4  1
2000 Pocernich CB, La Fontaine M, Butterfield DA. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochemistry International. 36: 185-91. PMID 10676851 DOI: 10.1016/S0197-0186(99)00126-6  1
Show low-probability matches.